Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
525 Open-label study of zopapogene imadenovec-drba retreatment and vector shedding evaluation in adult patients with recurrent respiratory papillomatosis
8 affiliations
- 1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
- 21Precigen, Inc. Germantown, MD , USA
- 3National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
- 4Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
- 5Precigen, Inc., Germantown, MD, USA
- 6Division of Laryngology, Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati Medical Center, Cincinnati, OH, USA
- 7Department of Hematology and Medical Oncology, The Winship Cancer Institute, Emory University, Atlanta, GA, USA
- 8Emory Voice Center, Emory University School of Medicine, Atlanta, GA, USA
Related
- 524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis
- Evaluation of the efficacy of a live attenuated vaccine (porcimune PRRS MLV) against porcine reproductive and respiratory syndrome virus in landrace piglets.
- Development and evaluation of an ARTIC-based amplicon sequencing assay for whole-genome characterization of respiratory syncytial virus
- Multiplex molecular respiratory diagnostic panels and antimicrobial use in paediatric respiratory infections: a systematic review and meta-analysis protocol.
- Differential requirements for cytokine signaling and local antigen in upper versus lower respiratory tract CD8+ TRM development
BibTeX
@article{schlom2026openlabel,
title = {{525 Open-label study of zopapogene imadenovec-drba retreatment and vector shedding evaluation in adult patients with recurrent respiratory papillomatosis}},
author = {Jeffrey Schlom and Helen Sabzevari and Amy Lankford and Gaetano Bonifacio and James L Gulley and Scott M Norberg and Roshanak T Semnani and Tasha B Tan and David M Dalton and Premkumar V Giridhar and Clint T Allen and Aaron D Friedman and Nabil F Saba and Adam M Klein and Rutul R Shah and Douglas E Brough},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0525},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0525},
note = {CC BY},
}
RIS
TY - JOUR
TI - 525 Open-label study of zopapogene imadenovec-drba retreatment and vector shedding evaluation in adult patients with recurrent respiratory papillomatosis
AU - Jeffrey Schlom
AU - Helen Sabzevari
AU - Amy Lankford
AU - Gaetano Bonifacio
AU - James L Gulley
AU - Scott M Norberg
AU - Roshanak T Semnani
AU - Tasha B Tan
AU - David M Dalton
AU - Premkumar V Giridhar
AU - Clint T Allen
AU - Aaron D Friedman
AU - Nabil F Saba
AU - Adam M Klein
AU - Rutul R Shah
AU - Douglas E Brough
PY - 2026
DA - 2026/11/08
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0525
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0525
SN - 2051-1426
ER -